Mirae Asset Global Investments
OKUR

Mirae Asset Global Investments’s OnKure Therapeutics OKUR Stock Holding History

Mirae Asset Global Investments’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-497
Closed -$1.37K – 1763
2025
Q3 		$1.37K Buy
497
+2
+0.4% +$5 ﹤0.01% 1638
2025
Q2 		$1.18K Buy
495
+72
+17% +$189 ﹤0.01% 1576
2025
Q1 		$1.89K Buy
423
+1
+0.2% +$6 ﹤0.01% 1541
2024
Q4 		$3.44K Buy
422
+301
+249% +$4.56K ﹤0.01% 1570
2024
Q3 		$2.01K Buy
121
+21
+21% +$311 ﹤0.01% 1539
2024
Q2 		$1.61K Buy
+100
New +$1.7K ﹤0.01% 1514

Other funds holding OKUR

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.4% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

Mirae Asset Global Investments's OKUR Position: Q4 2025 in Review

Mirae Asset Global Investments sold out of OnKure Therapeutics (OKUR) in Q4 2025, closing a stake of 497 shares — an estimated $1.37K sold.

Mirae Asset Global Investments first reported a position in OKUR in Q2 2024 and held it in 6 quarters. The position peaked at $3.44K in Q4 2024. 44 funds tracked by Wall St. Rank hold OKUR as of Q4 2025.

  • Mirae Asset Global Investments reported no remaining OnKure Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Mirae Asset Global Investments sold 497 OnKure Therapeutics shares in Q4 2025, an estimated $1.37K.
  • Mirae Asset Global Investments first reported a position in OnKure Therapeutics in Q2 2024 and held it in 6 quarters.
  • Mirae Asset Global Investments's OnKure Therapeutics position peaked at $3.44K in Q4 2024.
  • 44 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q4 2025.

Based on Mirae Asset Global Investments's 13F filing for Q4 2025, filed 26 Jan 2026.